Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Commentary: antibodies reacting with the infliximab Fab portion--something new? Authors' reply

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Autoimmune diseases in microscopic colitis: A Danish nationwide case-control study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Fibrogenesis and inflammation contribute to the pathogenesis of cirrhotic cardiomyopathy

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. All-cause and cause-specific mortality in microscopic colitis: a Danish nationwide matched cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Systematic review: gastric microbiota in health and disease

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Chronic Kidney Disease-Induced Vascular Calcification Impairs Bone Metabolism

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Tumor cell MT1-MMP is dispensable for osteosarcoma tumor growth, bone degradation and lung metastasis

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Monitoring CD8a+ T Cell Responses to Radiotherapy and CTLA-4 Blockade Using [64Cu]NOTA-CD8a PET Imaging

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Therapeutic thresholds and mechanisms for primary non-response to infliximab in inflammatory bowel disease

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations
Original languageEnglish
JournalAlimentary Pharmacology and Therapeutics
Volume38
Issue number5
Pages (from-to)552-3
Number of pages2
ISSN0269-2813
DOIs
Publication statusPublished - Sep 2013

ID: 42660506